Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations

• 收藏
• 分享

专利权人:

RHIZEN PHARMACEUTICALS SA

发明人:

Vakkalanka Swaroop K.

申请号：

US201515313454

公开号：

US9969740(B2)

申请日:

2015.05.26

申请国别(地区):

美国

年份:

2018

代理人:

Blank Rome LLP

摘要：

The present invention relates to solid state forms of a p-toluenesulfonic acid salt (PTSA) of the selective PI3K delta inhibitor (S)-2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one (TGR-1202). The present invention also relates to methods of preparing the same, pharmaceutical compositions containing them, and methods of treating a PI3K kinase mediated disease or disorder, such as cancer, by administering the same.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/